haemophilia B | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

20,012 results for “haemophilia B”

Pfizer's Gene Therapy Fidanacogene Elaparvovec Shows Promise in Haemophilia B Treatment

Be Biopharma Initiates First-in-Human Trial of CRISPR-Based Gene Therapy for Haemophilia B

UK and Denmark Approve CSL's Hemgenix Gene Therapy for Haemophilia B with Novel Reimbursement Models

FDA Lifts Clinical Hold on uniQure's Hemophilia B Gene Therapy

Be Bio Secures $82M to Advance Hemophilia B Gene Therapy BE-101 into Phase I/II Trial

European Commission Approves Pfizer's Hympavzi for Haemophilia A and B

FDA Approves First Anti-TFPI Antibody and Biparatopic Antibody Therapy

Pfizer Launches Beqvez Gene Therapy for Hemophilia B with Novel Warranty Program at $3.5M

European Regulators Recommend Expanding Novo Nordisk's Alhemo for Hemophilia A and B Without Inhibitors

Russia Registers First Efanesoctocog Alfa Drug for Haemophilia A as Nanolek Secures EAEU Rights to China's Armocibat

Page 1 of 392